Entasis: US FDA approves Entasis Therapeutics' Xacduro for treatment for pneumonia caused by certain difficulttotreat bacteria
The US Food and Drug Administration (FDA) approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital─acquired bacterial pneumonia (HABP) and ventilator─associated
Read full article »
Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections.
Read more